美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=ANDA090231"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
40032-090-19 40032-090 HUMAN PRESCRIPTION DRUG POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES POWDER, FOR SOLUTION ORAL 20090601 N/A ANDA ANDA090231 Novel Laboratories, Inc. POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS 236 g/274.31g; 2.97 g/274.31g; 6.74 g/274.31g; 5.86 g/274.31g; 22.74 g/274.31g 274.31 g in 1 BOTTLE (40032-090-19)
43386-090-19 43386-090 HUMAN PRESCRIPTION DRUG GAVILYTE G TM polyethylene glycol-3350 and Electrolytes POWDER, FOR SOLUTION ORAL 20090601 N/A ANDA ANDA090231 Lupin Pharmaceuticals,Inc. POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS 236 g/274.31g; 2.97 g/274.31g; 6.74 g/274.31g; 5.86 g/274.31g; 22.74 g/274.31g 274.31 g in 1 BOTTLE (43386-090-19)
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase